Impulsonics Completes Successful Field Testing with The Armstrong Group
Impulsonics is delighted to announce the successful conclusion of its first field testing in collaboration with The Armstrong Group at the University of Bristol.
Ximena Vasto at the Dorothy Hodgkins Building
Impulsonics’ Cell Biologist, Ximena Vasto, has been working closely with PhD candidate Norah-Jane Prendergast and Dr Mina Aleemardani to test the Impulsonics hardware in their labs at the renowned Dorothy Hodgkin Building. The tests involved three different cell lines, all of which demonstrated good compatibility with Impulsonics’ innovative approach to biotech automation.
“We have decades of evidence that acoustic waves can be used safely with cells,” said CEO Luke Cox, “but it’s nice to get some more validation on our specific hardware and techniques.”
James Armstrong, the Group’s leader, added, “This collaboration has been invaluable in proving the robustness of Impulsonics’ technology. We look forward to working further with Impulsonics to develop their solutions to advance lab automation globally.”
Impulsonics now plans to continue developing their technology further as part of their goal to create innovative automation systems for cell passaging, expanding their validation of capabilities in novel biological scenarios.
About Impulsonics
Impulsonics is a start-up dedicated to making biotech automation simple and scalable so scientists can focus on the problems that matter. Their unique technology leverages acoustic waves to move cells and particles around inside standard labware without touching them, streamlining existing processes and enabling unique new capabilities.
About The Armstrong Group
The Armstrong Group, based at the University of Bristol, is an interdisciplinary, collaborative research group known for innovating new biotechnologies for controlling the assembly of complex living systems.
For more information, visit The Armstrong Group.
To get regular updates on how Impulsonics is working to make biotech automation simple and scalable, subscribe here.